Search

everythinglearnresearchcommunity

for

Search:↓

TrichoFoam™ effectively delivers multiple hair loss treatments, maintaining their stability and effectiveness.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

A hydrogel releasing pectolinarin speeds up wound healing and reduces scarring.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

ITK inhibitors may effectively treat alopecia areata.

Adipose-derived stem cells and platelet-rich plasma together can protect skin and hair from radiotherapy damage.

Cold Plasma shows promise for healing wounds by killing bacteria and helping tissue grow.

Ch55 may help reduce skin scarring and fibrosis.

The nutritional supplement Pilopeptan® WOMAN improved hair growth and thickness in women with hair loss.

A new non-invasive laser system improves chronic disease management and metabolic health.

PTH-CBD agonists may help regrow hair after chemotherapy.

Baricitinib works better than methotrexate for severe alopecia areata.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

Yuperio combined with bisoprolol improves heart function in patients with dilated cardiomyopathy.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Antituberculosis drugs can cause severe skin reactions, requiring careful diagnosis and treatment.

The committee decided not to approve the drug due to low effectiveness and high risks.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

The hydrogel effectively treats oral mucositis by reducing oxidative damage and bacterial infection.

Combining TCA with 5-FU is more effective and safer for treating keloids than TCA alone.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Nanospanlastic vesicles can improve glaucoma treatment by enhancing drug delivery to the eye.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.